Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
REEVA (triclosan) Antibacterial Hand Soap and Dishwashing Liquid Recalled by Showline Automotive Products, Inc. dba US Soaps Mfg. Company Due to Microbial Contamination of a Non-Sterile Products: Product was...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Showline Automotive Products, Inc. dba US Soaps Mfg. Company directly.
Affected Products
REEVA (triclosan) Antibacterial Hand Soap and Dishwashing Liquid, Green Apple, 0.10%, 24 fl oz. bottle, Distributed by Aldi Inc,. Batavia, IL 60510; UPC 0 4198 1525 8.
Quantity: 11520 bottles
Why Was This Recalled?
Microbial Contamination of a Non-Sterile Products: Product was found to be contaminated with the bacteria, Sarcina Lutea.
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Showline Automotive Products, Inc. dba US Soaps Mfg. Company
Showline Automotive Products, Inc. dba US Soaps Mfg. Company has 1 total recall tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report